Advertisement
Research Article| Volume 30, ISSUE 12, P1191-1198, December 15, 1991

Download started.

Ok

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

  • A.D. Sherman
    Correspondence
    Address reprint request to A.D. Sherman, Department of Psychiatry, The University of Iowa, College of Medicine, 500 Newton Road, Iowa City, IA 52242.
    Footnotes
    Affiliations
    Department of Psychiatry, The University of Iowa, College of Medicine, Iowa City, USA
    Search for articles by this author
  • T.S. Hegwood
    Footnotes
    Affiliations
    Department of Psychiatry, The University of Iowa, College of Medicine, Iowa City, USA
    Search for articles by this author
  • S. Baruah
    Footnotes
    Affiliations
    Department of Psychiatry, The University of Iowa, College of Medicine, Iowa City, USA
    Search for articles by this author
  • R. Waziri
    Footnotes
    Affiliations
    Department of Psychiatry, The University of Iowa, College of Medicine, Iowa City, USA
    Search for articles by this author
  • Author Footnotes
    ∗∗ We thank Dr. Robert Robinson and Dr. Nancy Andreasen for their support. We also thank Dr. Wallace Tourtellote and his staff, who sent us the brain samples from the National Neurological Brain Band, VAMC, Wadsworth Division, Los Angeles, California 90073, which is sponsored by NINDS/NIMH, National Multiple Sclerosis Society, Huntington's Disease Foundation, Comprehensive Epilepsy Program, Tourette Syndrome Association, Dystonia Medical Research Foundation, Veterans Health Services and Research Administration, Department of Veteran Affairs.
DOI:https://doi.org/10.1016/0006-3223(91)90155-F
Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics
Previous ArticleThe association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients
Next ArticleLack of association between HLA-DR antigens and sleep-onset REM periods in major depression
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Previous studies from our laboratory indicated that the veratridine-induced release of glutamate and GABA from synaptosomes derived from brains of schizophrenics was decreased. In the present study, synaptosomes were prepared from frozen brain samples from schizophrenics and from controls. Stimulation by 10 μmol/L 2-amino-3-hydroxy-5-methoxylisoxazole-4-propionic acid (AMPA) produced equal glutamate release from both groups. Release induced by either 10 μmol/L kainic acid (KA) or n-methyl-d-asparate (NMDA) was reduced significantly in the preparations derived from schizophrenics. Similarly, the amount of GABA released by 50 μmol/L glutamate was also reduced in the schizophrenic-derived synaptosomes. However, in membranes derived from the crude synaptosomal pellet, no differences between the controls and schizophrenics were observed in measures of total glutamate binding or its displacement by NMDA. The data demonstrate a deficiency in NMDA (and possibly KA) receptor functioning in schizophrenics and support the “second-generation” theories of schizophrenia as a glutamatergic deficiency disorder.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Barrie A.
        • Nicholls D.G.
        Presynaptic regulation of glutamate release from guinea pig cortical synaptosomes.
        Biochem Soc Trans. 1988; 16: 881-882
        • Bogerts B.
        • Meertz E.
        • Schonfeld-Bausch R.
        Basal ganglia and limbic system pathology in schizophrenia.
        Arch Gen Psychiatry. 1985; 42: 784-791
        • Brown R.
        • Colter N.
        • Corsellis J.A.N.
        • et al.
        Postmortem evidence of structural brain changes in schizophrenia: Differences in brain weight, temporal brains parahyppochampus gyrus compared with affective disorder.
        Arch Gen Psychiatry. 1986; 43: 36-47
        • Deakin J.F.
        • Simpson M.
        • Gilchrist A.C.
        • et al.
        Changes in [3H] d-aspartate and [3H] kainate binding in schizophrenic postmortem brains.
        J Neurochem. 1989; 52: 1781-1786
        • Deutch S.I.
        • Mastropaolo J.
        • Schwartz B.L.
        • et al.
        A “glutamatergic hypothesis” of schizophrenia.
        Clin Neuropharmacol. 1989; 12: 1-13
        • Dodd R.
        • Watson W.E.J.
        • Johnston G.A.R.
        • et al.
        Uptake of γ aminobutyric acid and l-glutamic acid by synaptosomes from postmortem human cerebral cortex: Multiple sites sodium dependence and effect of tissue preparation.
        Brain Res. 1989; 490: 320-331
        • Gattaz W.F.
        • Gasser T.
        • Beckmann H.
        Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls.
        Biol Psychiatry. 1985; 20: 360-366
        • Hardy J.A.
        • Dodd P.R.
        • Oakley A.E.
        • Kidd A.M.
        • Perry R.H.
        • Edwardson J.A.
        Use of postmortem human brain synaptosomes for studies of metabolism and transmitter amino acid release.
        Neurosci Lett. 1982; 33: 317-323
        • Jakob H.
        • Beckmann H.
        Prenatal developmental disturbances in limbic allo cortex in schizophrenia.
        J Neural Transmfl21. 1986; 65: 303-326
        • Johnston E.C.
        In vivo and postmortem evidence of structural changes.
        in: Helchen H. Henn F.A. Biological Perspectives of Schizophrenia. Wiley, New York1987
        • Johnston E.C.
        • Owens D.G.
        • Crow T.J.
        • et al.
        Temporal lobe structures as determined by unclear magnetic resonance in schizophrenia and bipolar affective disorder.
        J Neurol Neurosurg Psychiatry. 1989; 52: 736-741
        • Kerwin R.W.
        • Patel S.
        • Meldrum B.S.
        • et al.
        Asymmetrical loss of glutamate receptor subtype in left hyppochampus in schizophrenia.
        Lancet. 1988; 1: 583-584
        • Kim J.S.
        • Kornhuber H.H.
        • Schmid-Burgk W.
        • et al.
        Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis of schizophrenia.
        Neurosci Lett. 1980; 20: 379-382
        • Kishimoto H.
        • Simon J.R.
        • Aprison M.H.
        Determination of the equilibrium disassociation constants and number of glycine binding sites in several areas of the rat central nervous system, using a sodium-independent system.
        J Neurochem. 1981; 37: 1015-1024
        • Korpi E.T.
        • Kaufman C.A.
        • Maruela K.M.
        • et al.
        Cerebrospinal fluid amino acid concentrations in chronic schizophrenia.
        Psychiatry Res. 1987; 20: 337-345
        • Lenda K.
        • Svenneby G.
        Rapid high performance liquid chromatographic determination of amino acids in synaptosomal extracts.
        J Chromatogr. 1980; 198: 516-519
        • Nagy A.
        • Delgado-Escueta A.V.
        Rapid preparation of synaptosomes from mammalian brain using non-toxic isosomotic gradient material (Percoll).
        J Neurochem. 1984; 43: 1114-1123
        • Nicholls D.G.
        Release of glutamate, aspartate and γ-aminobutyric acid from isolated nerve terminals.
        J Neurochem. 1989; 52: 331-341
        • Perry T.L.
        Normal cerebrospinal fluid and brain glutamate levels in schizophrenics do not support the hypothesis of glutamatergic neuronal dysfunction.
        Neurosci Lett. 1982; 28: 81-85
        • Perry T.L.
        • Kish S.G.
        • Buchannan
        • et al.
        γ aminobytric acid deficiency in brains of schizophrenic patients.
        Lancet. 1979; 1: 237-239
        • Sherman A.D.
        • Davidson A.T.
        • Baruah S.
        • et al.
        Evidence of glutamatergic deficiency in schizophrenia.
        Neurosci Lett. 1991; 121: 77-80
        • Simpson M.D.C.
        • Slater P.
        • Deakin M.C.
        • et al.
        Reduced GABA uptake sites in the temporal lobes in schizophrenics.
        Neurosci Lett. 1989; 107: 211-215
        • Suddath R.L.
        • Casanova M.F.
        • Goldberg T.E.
        • et al.
        Temporal lobe pathology in schizophrenia: A qualitative magnetic resonance imaging study.
        Am J Psychiatry. 1989; 146: 464-472
        • Szerb J.C.
        Rate limiting steps in the synthesis of GABA and glutamate.
        in: Avoli M. Reader T.A. Dykes R.W. Neurotransmitters and Cortical Function. Plenum, New York1988: 153-166

      Article info

      Publication history

      Received in revised form: July 27, 1991
      Received: April 17, 1991

      Footnotes

      ☆This work was partially supported by the MHCRC NIMH Grant #5P50MH43271.

      Identification

      DOI: https://doi.org/10.1016/0006-3223(91)90155-F

      Copyright

      © 1991 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX